课题基金 / 基金详情

Genetic, Epigenetic and Proteomic Analysis of the Kallikrein Family in Search for Novel Diagnostic Prognostic and Risk Susceptibility Algorithms for Prostate Cancer

Genetic, Epigenetic and Proteomic Analysis of the Kallikrein Family in Search for Novel Diagnostic Prognostic and Risk Susceptibility Algorithms for Prostate Cancer
激肽释放酶家族的遗传学、表观遗传学和蛋白质组学分析,寻找前列腺癌的新诊断预后和风险易感性算法
批准号:
183795
负责人:
Diamandis Eleftherios P
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-10-01 至 2009-10-01

项目摘要

项目成果

Diamandis Eleftherios P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PCa), the most common cancer in men is a major health problem. The PSA blood test, which is a human kallikrein 3 (KLK3), has dramatically changed the presentation of PCa and increased the number of detectable early-stage and therefore tre
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KaliDerm Therapeutics: A research/commercialization plan to validate, better define and add value to our proprietary dual KLK5/7 inhibitor as a novel topical therapeutic for Netherton Syndrome.
  • 批准号:
    462430
  • 项目类别:
    Operating Grants
  • 资助金额:
    $24.52万
  • 财政年份:
    2022
  • 负责人:
    Diamandis Eleftherios P
  • 依托单位:
Integrative PersonalizedRiskand Therapy Stratification of Localized Prostate Cancer
  • 批准号:
    388062
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.78万
  • 财政年份:
    2018
  • 负责人:
    Diamandis Eleftherios P
  • 依托单位:
Netherton Syndrome: From mechanism to therapies.
  • 批准号:
    331997
  • 项目类别:
    Operating Grants
  • 资助金额:
    $5.15万
  • 财政年份:
    2015
  • 负责人:
    Diamandis Eleftherios P
  • 依托单位:
Validation of two novel pancreatic cancer biomarkers: CUZD1 and LAMC2
  • 批准号:
    279678
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.86万
  • 财政年份:
    2013
  • 负责人:
    Diamandis Eleftherios P
  • 依托单位:
海外基金